A total of 230 patients were studied under controlled trial, all suffering from Prostate carcinoma. All of these patients were transfused with 60 million organ specific killer stem cells which were modified from hemopoeitic stem cells of umbilical cord. As post stem cell booster Imatinib 400 mg od plus Pazopanib 400 mg od were used. In scans done 1 month post stem cell all these patients showed 20% clearance in primary lesions. Scans done 3 months post stem cell showed 70% clearance and bone scan done at 6 months showed full clearance. All mets also got cleared by 6 months.
Organ specific killer stem cells modified from pleuripotent hemopoeitic umbilical cord stem cells are curative for Carcinoma of Prostate. Imatinib and Pazopanib are potent post stem cell boosters in Prostate cancer.